|
Market Cap (17-May) $40,671,720 (1,053rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 400,697 |
Shortsold (10-Dec) 1,128,575 (0.62%) (255th) |
|
52w High $0.345 |
52w Low $0.140 |
P/E - |
EPS -0.05 |
CYP released this announcement to the ASX on 14 October 2021, 17:17. The announcement is not marked as price sensitive, and is 96 page(s) in length and 11.61MB in size.
You can view all announcements from CYP and see how they appear on a price chart on the announcements page.
At the date of this announcement, CYP was 0.004% short sold according to ASIC data. It was ranked the 644th most shorted stock on the ASX. It is now ranked as the 255th most shorted stock on the ASX with 0.624% of total shares short sold as of the latest reported data (10 December 2024).
| Other Recent Announcements from CYP | |
|---|---|
| Notification regarding unquoted securities - CYP | 30 June 2023, 13:10 |
| Proposed issue of securities - CYP | 30 June 2023, 9:44 |
| Cynata announces CEO succession and Board changes | 30 June 2023, 9:13 |
| Annual Report to shareholders | 14 October 2021, 17:17 |
| Letter to Shareholders & Notice of Annual General Meeting | 14 October 2021, 17:07 |
| Notification regarding unquoted securities - CYP | 12 October 2021, 17:13 |
| DSMB Recommends Continuation of Cynata's MEND Trial | 8 October 2021, 9:23 |
You must be logged in to post a reply.
Cynata Therapeutics 